Nuventra Pharma Sciences Named a TBJ Fast 50 Award Winner for Third Consecutive Year
Nuventra Pharma Sciences is pleased to announce that it has been ranked as a part of the Triangle Business Journal’s Fast 50 List honoring the 50 fastest growing privately held…
Read More
Former FDA Reviewers Brian Furmanski & Gene Williams Join Nuventra Pharma Sciences as Senior Consultants
Nuventra Pharma Sciences is pleased to announce the addition of two former FDA reviewers, Brian Furmanski Ph.D. and Gene Williams Ph.D., to its growing team of experienced consultants. Both offer a…
Read More
Nuventra’s Senior Consultants to Speak about the Path to IND at September’s LaunchBio Event
Nuventra Pharma Sciences will present at LaunchBio’s Larger Than Life Science Event on Thursday, September 6, 2018. This monthly event series features networking opportunities, workshops, and panel discussions led by…
Read More
Nuventra Ranks on Inc. 5000 List for Fifth Consecutive Year
Inc. Magazine announced today that Nuventra Pharma Sciences has once again ranked on the Inc. 5000 list for 2018. This marks the fifth year in a row that Nuventra has…
Read More
Nuventra Pharma Sciences Announces New Office Location in Cambridge, Massachusetts
Nuventra Pharma Sciences is pleased to announce the opening of a new office in Cambridge, Massachusetts, located in the Greater Boston Area. The office will be located at One Alewife…
Read More
Nuventra Pharma Sciences to Present at ASCPT Annual Meeting
Nuventra is proud to announce its participation at the American Society for Clinical Pharmacology & Therapeutics (ASCPT) Annual Meeting and Exposition on March 21 – 24, 2018 in Orlando, FL. Nuventra’s scientists…
Read More
Nuventra’s Chief Scientific Officer Elected as 2019-2020 ASCPT President
Nuventra is proud to announce that David Y. Mitchell, Ph.D., Chief Scientific Officer, has been elected as President-Elect of the American Society for Clinical Pharmacology and Therapeutics (ASCPT). Dr. Mitchell…
Read More